Seeking Alpha29m
Eli Lilly: An Early Christmas Present Has Just Arrived (Rating Upgrade)
Eli Lilly and Company (NYSE:LLY) investors who chased the stock toward its July/August 2024 highs have likely been ...
Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?
Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion ...
MarketBeat on MSN59m
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 ...
Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney
Former Wisconsin Rep. Mike Gallagher joined 'America's Newsroom' to discuss Trump's tariff threat against China and his ...
'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing Dispute
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...
Campaign US23h
Chief corporate brand officer Lina Polimeni on Eli Lilly’s ‘big evolution’ in marketing
Eli Lilly and Company chief corporate brand officer Lina Polimeni described the new format as a “big evolution” in the company’s marketing, shifting its focus to the Lilly brand, its patients and an ...
Eli Lilly downgraded to Hold from Buy at Erste Group
Erste Group downgraded Eli Lilly (LLY) to Hold from Buy.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...
GlobalData on MSN20h
MHRA approves Eli Lilly’s Alzheimer’s diagnostic imaging agent Tauvid
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Tauvid (flortaucipir), a diagnostic imaging ...